CA 02504797 2005-05-03
OP05014
SPECIFICATION
Base for Oral Composition and the Oral Composition
Technical Field:
The present invention relates to a base for oral compositions. In
particular, the present invention relates to a base for oral compositions
suitable
for the use for preparing water-free or substantially water-free oral
compositions.
The present invention also relates to an oral composition containing the base
for
the oral composition.
Background Art:
Oral compositions such as dentifrices generally contain a binding agent
such as sodium carboxymethyl cellulose, carrageenan or xantham gum. When
such a component is dissolved in water, it becomes viscous and binds a powder
component such as an abrasive with a liquid component to realize a shape
retention or a suitable viscosity.
Therefore, in water-free oral compositions such as dentifrices, it is
difficult
to keep the shape retention because of the lack in the viscosity and, as a
result, a
powdery component is separated from a liquid component in the oral composition
with time.
On the other hand, various active ingredients are sometimes contained in
the oral compositions such as dentifrices for the purpose of imparting some
functions or effects to them. The active ingredients include components for
accelerating remineralization (recrystalization), fluorides, sterilizers,
anti-inflammatory agents, hemostatics and various enzymes.
The components for accelerating remineralization (recrystalization)
include calcium phosphate compounds such as hydroxyapatite. In these
1
CA 02504797 2005-05-03
OP05014
compounds, a -tricalcium phosphate (hereinafter referred to as " a -TCP") is
known to exhibit an extremely high effect of accelerating remineralization
(recrystalization) in the oral cavity and also to be effective in preventing
and
repairing tooth decay. However, on the other hand, cx -TCP is converted to an
apatite compound in the presence of water. This reaction is accelerated in the
presence of a fluoride or a water-soluble calcium phosphate to cause a self
curing
reaction. Thus, ce -TCP could not be stably contained in oral compositions
such
as ordinary water-containing dentifrices.
The fluorides include sodium fluoride, potassium fluoride, sodium
monofluorophosphate, tin fluorides, etc. The effect of the fluorides is that
hydroxyapatite of teeth is fluorinated with fluorine ion to improve the
quality of
the teeth. When a fluoride is contained into an ordinary water-containing oral
composition such as a dentifrice, fluorine ion is dissolved in water in the
oral
composition and then adsorbed on other components such as an abrasive not to
develop the exhibition of the essential effect of fluorine ion. For example,
it is
known that in a water-containing oral composition which also contains a sodium
fluoride or a tin fluoride and an abrasive such as calcium phosphate or
calcium
carbonate, fluorine ion adsorbs on the abrasive to inactivate fluorine ion.
The enzymes include, for example, lysozyme, mutanase, protease, amylase
and dextranase. Many of these enzymes have a problem that when such an
enzyme is contained into a water-containing composition, it causes the
hydrolysis
to lower the enzymatic activity. Therefore, when such an enzyme is to be
contained into such a water-containing composition, a difficultly decomposable
enzyme must be selected or a method for stably incorporating each enzyme must
be selected.
Hinokitiol as a natural sterilizer or E-aminocaproic acid as a hemostatic is
contained into an oral composition such as a dentifrice in some cases.
However,
when such an active ingredient is contained into a water-containing
composition,
2
CA 02504797 2005-05-03
OP05014
the quantitative values thereof are inclined to be lowered by the hydrolysis.
Further, it is known that ascorbic acid and salts thereof are effective on the
hemorrhage in cases of gingivitis and periodontitis, etc. However, the
decomposition reaction thereof easily proceeds in the presence of water to
lower
the content of ascorbic acid or a salt thereof and also to cause coloring of
the
composition.
All the problems of the stability of these active ingredients are caused by
water contained in the oral compositions such as dentifrices. Under these
conditions, it is demanded to develop a substantially water-free oral
composition
such as a dentifrice which can stably contain a -TCP, fluorides, enzymes,
hinokitiol, E-aminocaproic acid, ascorbic acid, etc. and which can have a
shape-retaining property and wherein the separation of the powdery component
from the liquid component with time does not occur.
As bases for the oral composition, which are suitable for substantially
water-free or non-aqueous oral composition, for example, bases containing agar
or
gelatin were proposed in Japanese Patent Unexamined Publication No.
2002-11465G~ bases containing polyethylene powder or polyethylene wax were
proposed in Japanese Patent Unexamined Publication No. 2002-11465'l~ and
bases containing polyvinylpyrrolidone were proposed in Japanese Patent
Unexamined Publication No. 2002-255772.
Disclosure of the Invention:
An object of the present invention is to provide a base for oral compositions
suitable for the preparation of water-free or substantially water-free oral
compositions. Another object of the present invention is to provide a base for
Oral
compositions suitable for the preparation of water-free or substantially water-
free
oral compositions excellent in the shape-retaining property which compositions
are free from the separation of the components and stable with time. Still
3
CA 02504797 2005-05-03
OP05014
another object of the present invention is to provide a base for an oral
composition
capable of stably containing active ingredients which are generally unstable
in the
presence of water. A further object of the present invention is to provide an
oral
composition stably containing active ingredients which are generally unstable
in
the presence of water, in particular, a water-free or substantially water-free
oral
composition.
After intensive investigations made for the purpose of attaining the
above-described objects, the inventors have found that a highly stable oral
composition can be provided by using a base for oral compositions comprising
specified components. The present invention has been completed on the basis of
this finding.
Namely, the present invention relates to a base for non-aqueous oral
compositions, which contains hydroxypropyl cellulose and at least one
component
selected from the group consisting of concentrated glycerol, diglycerol,
propylene
glycol, 1,3-butylene glycol and polyethylene glycols. In a preferred
embodiment,
the present invention also provides the base for non-aqueous oral
compositions,
which further contains at least one component selected from the group
consisting
of silicic acid anhydride and crystalline cellulose.
The present invention also relates to an oral composition containing the
above-described base for oral composition. In an embodiment of the present
invention, the oral composition is preferably a non-aqueous oral composition.
The term "non-aqueous oral composition" herein indicates an oral
composition having a water content of 0 to 3 % by weight, preferably 0 to 1 %
by
weight and more preferably 0 % (completely free of water), based on the whole
composition. A base suitable for the preparation of such a non-aqueous oral
composition is herein represented as "base for non-aqueous oral composition".
The present invention also relates to an oral composition containing the
above-described base for the oral composition and an active ingredient
unstable in
4
CA 02504797 2005-05-03
OP05014
the presence of water. The active ingredients unstable in the presence of
water
include, for example, a -tricalcium phosphate ( ~: -TCP), fluorides, enzymes,
hinokitiol, f -aminocaproic acid, ascorbic acid and ascorbic acid salts.
Concretely, the oral composition of the present invention contains the
above-described base for the oral composition and at least one of the
above-described active ingredients unstable in the presence of water.
Concretely, the oral composition of the present invention comprises the
above-described base for the oral composition and at least one active
ingredient
unstable in the presence of water, which is selected from the group consisting
of
a -tricalcium phosphate ( c~ -TCP), fluorides, enzymes, hinokitiol, c-
aminocaproic
acid, ascorbic acid and ascorbic acid salts.
An embodiment of the present invention is an oral composition containing
the above-described base for the oral composition and a -tricalcium phosphate
( a
-TCP). Another embodiment of the present invention is an oral composition
containing the above-described base for the oral composition and at least one
fluoride. Still another embodiment of the present invention is an oral
composition containing the above-described base for the oral composition and
at
least one of the enzymes. A further embodiment of the present invention is an
oral composition containing the above-described base for the oral composition
and
hinokitiol. Another embodiment of the present invention is an oral composition
containing the above-described base for the oral composition and E-
aminocaproic
acid. Another embodiment of the present invention is an oral composition
containing the above-described base for the oral composition and at least one
component selected from the group consisting of ascorbic acid and salts
thereof.
A preferred embodiment of the oral composition of the present invention is
an oral composition comprising a combination of the above-described base for
the
oral composition with a -TCP and a fluoride.
5
CA 02504797 2005-05-03
OP05014
The Best Embodiment for Carrying out the Invention:
The term "oral composition" herein indicates dentifrices such as
toothpastes, liquid (gel) dentifrices and moist dentifrices, creams,
ointments,
pastes, mouth refrigerants, mouthwashes, chewing gums and gargles. The oral
composition of the present invention is desirably a non-aqueous oral
composition.
The hydroxypropyl cellulose contained in the base for the oral composition
of the present invention is a nonionic cellulose derivative obtained by
reacting
cellulose with propylene oxide. The hydroxypropyl cellulose has various
viscosities depending on the degree of polymerization of the molecule thereof.
The viscosity of the hydroxypropyl cellulose having a low viscosity is about 1
to 4
mPa/S and that having a high viscosity is as high as about 1000 to 5000 mPa/S.
For the determination of the viscosity (mPa/S), 2 % aqueous hydroxypropyl
cellulose solution is used as the sample and also a rotational viscometer is
used.
In the present invention, hydroxypropyl cellulose having a viscosity
ranging from a low viscosity to a high viscosity can be used. Namely,
hydroxypropyl cellulose can be selected from those having a viscosity of 1 to
5000
mPa/S. ~vo or more kinds of hydroxypropyl cellulose having different
viscosities
can also be used. In the present invention, hydroxypropyl cellulose having a
viscosity in the range of 150 to 4000 mPa/S is preferably used.
Such a hydroxypropyl cellulose is widely used for the preparation of
medicines, cosmetics, vinyl polymers, ceramics for parts of electric
appliances and
sintering agents in fluorescent lamp tubes. In the present invention,
hydroxypropyl cellulose thus available on the market is usable.
The amount of one or more kinds of hydroxypropyl cellulose having
different viscosities in the oral composition is 0.1 to 15 % by weight,
preferably 0.5
to 10 % by weight, based on the whole oral composition. In view of the
intended
effects of the present invention and the usefulness of the oral composition,
the
suitable amount of hydroxypropyl cellulose is in the above-described range.
G
CA 02504797 2005-05-03
OP05014
The base for the oral composition of the present invention further contains
at least one component selected from the group consisting of concentrated
glycerol,
diglycerol, propylene glycol, 1,3-butylene glycol and polyethylene glycol.
Among
them, propylene glycol and 1,3-butylene glycol are particularly preferred.
Concentrated glycerol, diglycerol, propylene glycol, 1,3-butylene glycol and
polyethylene glycol are widely and generally used for the preparation of
medicines,
cosmetics, foods and miscellaneous goods as well as in petrochemical industry
and
dye industry. In the present invention, those available on the market are
usable.
The amount of at least one of concentrated glycerol, diglycerol, propylene
glycol, 1,3-butylene glycol and polyethylene glycol is 10 to 85 % by weight,
preferably 20 to GO % by weight, based on the whole oral composition. For
obtaining the preferred usefulness of the oral composition, the amount of such
a
component must be in this range.
The base for the oral composition of the present invention can further
contain sihcic acid anhydride and/or crystalline cellulose.
Sihcic acid anhydride is silicon dioxide in the form of a white powder.
Silicic acid anhydride can be synthesized by treating sodium silicate with an
acid
to precipitate silicon dioxide, gelling and aging silicon dioxide and drying
and then
pulverizing the obtained product. Silicic acid anhydride having a weight loss
on
drying of not larger than 13 % and an ignition loss of not larger than 18 % is
preferred. The term "weight loss on drying" herein indicates the amount (% by
weight) of the components evaporated after heating 1 g of sihcic acid
anhydride at
105°C for 2 hours, and the term "ignition loss" herein indicates the
amount (% by
weight) of the components evaporated after heating 1 g of silicic acid
anhydride at
850°C for 30 minutes.
Such sihcic acid anhydride is widely and generally used for the
preparation of foods and cosmetics, as well as medicines, agricultural and
horticultural preparations, foods for living things, in ink industry, rubber
industry
7
CA 02504797 2005-05-03
OP05014
and plastic industry.
Silicic acid anhydride content of the oral composition is 0.5 to 30 % by
weight, preferably 3 to 15 % by weight, based on the whole oral composition.
In
view of the intended effects of the present invention and the usefulness of
the oral
composition, the suitable amount of silicic acid anhydride is in the
above-described range.
The term "crystalline cellulose" indicates a cellulose crystallite polymer
having a substantially constant degree of polymerization, which is obtained by
hydrolyzing a-cellulose, obtained in the form of a pulp from a fibrous plant,
with
an acid or an alkali.
The crystalline cellulose is widely and generally used for the preparation
of foods and cosmetics as well as medicines, agricultural and horticultural
preparations and foods for living things.
Crystalline cellulose content of the oral composition of the present
invention is 0.5 to 30 % by weight, preferably 3 to 10 % by weight, based on
the
whole oral composition. In view of the intended effects of the present
invention
and the usefulness of the oral composition, the suitable amount of the
crystalline
cellulose is in the above-described range.
In the present invention, the above-described base for the oral composition
can be combined with various components such as additives and active
ingredients generally used for the oral composition.
The base for the oral composition of the present invention can be
advantageously combined with an active ingredient which is generally unstable
in
the presence of water. Such active ingredients include, for example, a -TCP,
fluorides, enzymes, hinokitiol, f -aminocaproic acid, ascorbic acid and
ascorbic
acid salts.
The term " a -TCP" used for the preparation of the oral composition of the
present invention is a-tricalcium phosphate (3Cas(P04)z ~ Ca(OH)~) which is
widely
8
CA 02504797 2005-05-03
OP05014
and generally used for the preparation of medicines, cosmetics, foods and
miscellaneous goods as well as in petrochemical industry. In the present
invention, a -TCP available on the market is usable.
n; -TCP content of the oral composition of the present invention is 0.1 to
50 % by weight, preferably 1 to 30 % by weight, based on the whole oral
composition. For exhibiting the remineralization (recrystahzation) effect of a
-TCP, a -TCP content must be at least 0.1 % by weight. On the other hand,
when a -TCP content is over 50 % by weight, the usability of the oral
composition
might be damaged.
When a-TCP is used in combination with a fluoride, an extremely
excellent effect is exhibited because of the combination of the
remineralization
(recrystalization) effect with the supply of fluorine ion. Therefore, the
combination of a-TCP with a fluoride which will be described below is
preferably
used.
Concretely, the fluorides used in the present invention include sodium
fluoride, potassium fluoride, sodium monofluorophosphate, tin fluorides, etc.
At
least one of these fluorides can be used. These fluorides are generally widely
used for the preparation of medicines, cosmetics, etc. In the present
invention,
those available on the market can be used.
The fluoride content of the oral composition of the present invention is
0.01 to 3 % by weight based on the whole oral composition, and it is
preferably 100
to 1000 ppm in terms of fluorine in the oral composition such as a dentifrice.
Preferred fluorides are sodium fluoride and sodium monofluorophosphate.
Examples of the enzymes usable for the oral composition of the present
invention include lysozyme, mutanase, protease, amylase, dextranase and the
like.
One or more of these enzymes can be used. These enzymes are generally widely
used for the preparation of medicines, cosmetics, foods, etc. In the present
invention, those available on the market can be used.
9
CA 02504797 2005-05-03
OP05014
The enzyme content of the oral composition of the present invention is
0.01 to 5 % by weight, preferably 0.1 to 2 % by weight, based on the whole
oral
composition.
Preferred enzymes are lysozyme and amylase.
Hinokitiol used for the preparation of the oral composition of the present
invention is a crystalline acidic compound which is a specific component
contained
in natural Aomori hinoki trees. Other kinds of trees containing hinokitiol
are,
for example, Taiwanese hlnoki trees and Western red cedar trees in North
America. Hinokitiol having a strong antibacterial activity and a wide
antimicrobial spectrum is one of few natural sterilizers.
Hinokitiol as described above is generally widely used for the preparation
of foods, cosmetics, medicines, agricultural and horticultural preparations,
construction materials, foods for living things, etc. In the present
invention,
those available on the market can be used.
Hinokitiol content of the oral composition of the present invention is 0.005
to 0.5 % by weight, preferably 0.01 to 0.2 % by weight, based on the whole
oral
composition.
~-Aminocaproic acid used for the preparation of the oral composition of the
present invention is a component having anti-plasmin effect, hemostatic effect
and anti-inflammatory effect and generally widely used for the preparation of
cosmetics, medicines, foods and agricultural and horticultural preparations.
In
the present invention, E-aminocaproic acid available on the market can be
used.
~-Aminocaproic acid content of the oral composition of the present
invention is 0.001 to 1 % by weight, preferably O.OOG to 0.2 % by weight,
based on
the whole oral composition.
Ascorbic acid used for the preparation of the oral composition of the
present invention is so-called vitamin C. Concretely, ascorbic acid herein
indicates L-ascorbic acid (CsHaO~=17G) and salts thereof. Concretely, the
CA 02504797 2005-05-03
OP05014
ascorbic acid salts used herein include sodium ascorbate, potassium ascorbate,
calcium ascorbate, magnesium ascorbate, etc. The oral composition of the
present invention can contain one or more components selected from the group
consisting of ascorbic acid and salts thereof. In the ascorbic acid salts,
sodium
ascorbate is preferably used.
Ascorbic acid and the salts thereof are components having
anti-inflammatory effect and also effect of accelerating the synthesis of
collagen
fibers. They are generally widely used for the preparation of cosmetics,
medicines, foods, and agricultural and horticultural preparations. In the
present
invention, those available on the market can be used.
The amount of at least one component selected from the group consisting
of ascorbic acid and salts thereof in the oral composition of the present
invention
is 0.001 to 20 % by weight, preferably 0.01 to 10 % by weight, based on the
whole
oral composition.
As described above, the active ingredients which can be suitably used in
combination with the base for the oral composition of the present invention
are (1)
a -TCP~ (2) ffuorides~ (3) enzymes (4) hinokitioh (5) f -aminocaproic acid and
(G)
ascorbic acid and salts thereof. One or more compounds selected from the group
consisting of these components (1) to (G) can be contained into the oral
composition. Two or more compounds can be selected from two or more of these
groups and used together. In particular, the combination of a -TCP with the
fluoride is preferred.
The oral composition of the present ilivention can contain, if necessary,
components which will be described below in an ordinary amount, in addition to
the above-described components, depending on the kind of the composition.
<Abr asives>
The abrasives include silica abrasives such as silica gel, precipitated
silica,
igneous silica, hydrated silicic acid, zeolite, aluminosilicate and
zirconosilicate~ as
11
CA 02504797 2005-05-03
OP05014
well as dicalcium phosphate dihydrate, anhydrous dicalcium phosphate, calcium
pyrophosphate, magnesium tertiary phosphate, tricalcium phosphate, aluminum
hydroxide, alumina, light calcium carbonate, heavy calcium carbonate,
magnesium carbonate, zirconium silicate and synthetic resin abrasives. They
can be used either alone or in combination of two or more of them. The amount
of the abrasive is preferably 3 to GO % by weight, more preferably 10 to 45 %
by
weight, based on the whole composition.
<Humectants>
One or more of polyhydric alcohols such as sorbitol and maltitol are
usable.
<Foaming agents>
The foaming agents include, for example, sodium lauryl sulfate, sodium
lauroyl sarcosine, sodium alkyl sulfosuccinates, sodium coconut oil fatty acid
monoglycerol sulfonates, sodium a-olefin sulfonates, N-acylamino acid salts
such
as N-acyl glutamate, 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium
betaine, maltitol fatty acid esters, sucrose fatty acid esters, polyglycerol
fatty acid
esters, fatty acid diethanolamides, polyoxyethylene sorbitan monostearate,
polyoxyethylene hydrogenated castor oil and polyoxyethylene fatty acid esters.
These foaming agents are usable either alone or in combination of two or more
of
them.
<Sweeteners>
The sweeteners include, for example, saccharin sodium, aspartame,
trehalose, stevioside, stevia extract, p-methoxycinnamic aldehyde,
neohesperidyldihydrochalcone and perillartine. These sweetening agents are
usable either alone or in combination of two or more of them.
<Antiseptics>
The antiseptics include, for example, p-hydroxybenzoate esters such as
methylparaben, ethylparaben, propylparaben and butylparaben, sodium benzoate,
12
CA 02504797 2005-05-03
OP05014
phenoxyethanol and alkyldiaminoethylglycine hydrochlorides. These antiseptics
are usable either alone or in combination of two or more of them.
<Flavoring components>
The flavoring components include, for example, 1-menthol, anethole,
menthone, cineole, limonene, carvone, methyl salicylate, ethyl butyrate,
eugenol,
thymol, cinnamic aldehyde and trans-2-hexenal. These flavoring components
are usable either alone or in combination of two or more of them. They can be
used as they are or in the form of an essential oil containing them.
The above-described flavoring components may be used in combination
with other flavoring components such as aliphatic alcohols and esters thereof,
terpene hydrocarbons, phenol ethers, aldehydes, ketones and lactones as well
as
essential oils so far as the effect of the present invention is not disturbed.
The
amount of the flavors is preferably 0.02 to 2 % by weight based on the whole
composition.
<Active ingredients>
The active ingredients include, for example, zeohte, chlorhexidine salts,
cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride,
bisabolol, triclosan, isopropylmethylphenol, tocopherol acetate, tranexamic
acid,
dihydrocholesterol, polyvinylpyrrolidone, glycyrrhetinic acid, glycyrrhizinic
acid
salts, copper chlorophyllin salts, sodium chloride and guaiazulene sulfonate.
They are usable either alone or in combination of two or more of them.
<Others>
Other components usable herein are, for example, coloring matters such
as Blue No. 1, pigments such as titanium oxide, antioxidants such as
dibutylhydroxytoluene, and corrigents such as a liquid extracted from cha by
dry
distillation and sodium glutamate.
When 3 % by weight or less of water is contained into the oral composition
of the present invention, binding agents as described below can be contained,
if
13
CA 02504797 2005-05-03
OP05014
necessary, into the composition comprising the above-descnbed components.
<Binding agents>
The binding agents include, for example, carrageenan ( c , ~, , r ), alginic
acid, alginic acid salts and derivatives thereof such as sodium alginate,
alginic
acid propylene glycol ester, calcium-containing sodium alginate, potassium
alginate, calcium alginate and ammonium alginate, xantham gum, guar gum,
gelatin, agar, sodium carboxymethyl cellulose, hydroxyethyl cellulose and
polysodium acrylates. They are usable either alone or in combination of two or
more of them.
The oral composition comprising the combination of the above-described
components can be prepared by an ordinary method which is not particularly
limited.
The composition such as a tooth paste obtained as described above can be
stuffed into aluminum tubes, laminate tubes, glass vapor-deposited tubes,
plastic
tubes, plastic bottles, aerosol vessels, etc.
Examples
The following Examples and Comparative Examples will further illustrate
the present invention, which by no means limit the invention. Various tooth
pastes each having a composition shown in Tables 1 to 4 (unit: weight %) were
prepared by an ordinary method and then tested as will be described below. The
test results are summarized in Tables 1 to 4.
1. Tooth paste storability tests
Tooth pastes shown in Table 1 were prepared and then stored under severe
conditions as shown below. After the storage under severe conditions, the
conditions of the respective tooth pastes were organoleptically evaluated
according to the following evaluation standards:
[Severe storage conditions]
1. Storage in a constant temperature bath at GO°C for one month
14
CA 02504797 2005-05-03
OP05014
2. Storage in a constant temperature bath at 50°C for tvvo months
[Evaluation standard]
O: The state of the tooth paste was the same as that immediately after the
prep aration.
X : The separation of the solid component from the liquid component was
confirmed.
Table 1
Example Comparative
Example
Component (%)
1 2 1 2 3 4
Hydroxypropylcellulose
2.0 2.0
(Viscosity 150-400 mPa/S)
1,3-Butylene glycol G1.8 49.8 63.8 51.8 48.8 48.8
Silicic acid anhydride - 12.0 - 12.0 12.0 12.0
Carrageenan - - - - 3.0 -
Sodium
- - - - - 3.0
carboxymethylcellulose
Aluminum hydroxide 35.0 35.0 35.0 35.0 35.0 35.0
Sodium lauryl sulfate 1.0 1.0 1.0 1.0 1.0 1.0
Saccharin sodium 0.1 0.1 0.1 0.1 0.1 0.1
Ethylparaben 0.1 0.1 0.1 0.1 0.1 0.1
Total 100.0 100.0 100.0 100.0 100.0 100.0
State stability after
storage O O X X X X
at GOC for 1 month
State stability after
storage O O X X X X
at 50C for 2 months
CA 02504797 2005-05-03
OP05014
2. Fluorine ion determination test
Tooth pastes shown in Table 2 were prepared and stored under severe
conditions shown below. After the storage under severe conditions, a
predetermined amount of the tooth paste was taken and dispersed in water. The
obtained aqueous dispersion was immediately centrifuged to separate the
dispersion into an aqueous layer and a solid layer. Fluorine ion concentration
in
the liquid layer was determined with a fluorine ion meter. Fluorine ion
detected
in this sample was considered to be active fluorine ion which was not adsorbed
on
other components in the tooth paste. The residual rate of active fluorine ion
was
determined according to formula (1) given below.
[Severe storage conditions]
1. Storage in a constant temperature bath at GO°C for one week
2. Storage in a constant temperature bath at GO°C for two weeks
[Formula ( 1)]
Residual rate (%) _ [(Amount of fluorine ion after the storage under the
severe conditions) / (Amount of fluorine ion immediately after the
preparation of tooth paste)
When fluorine ion residual rate, i. e. active fluorine ion content, of the
tooth paste stored under the severe conditions was 80 % or higher, the
fluoride
was judged to be stable.
The storability tests of the tooth pastes shown in Table 2 were carried out
in the same manner as that in above item 1.
1G
CA 02504797 2005-05-03
OP05014
Table 2
Example Comp. Ref.
) Ex.
(
Components 3 4 5 G Ex.l
%
Hydroxypropylcellulose
3.0 3.0 - - 3.0
(Viscosity
150-400
mPa/S)
1,3-Butylene GO.G 48.G - 48.G 18.G
glycol
Silicic acid - 12.0 12.0 12.0 12.0
anhydride
Carrageenan - - 2.0 3.0 -
Water - - 49.G - 30.0
Sodium fluoride 0.2 0.2 0.2 0.2 0.2
Calcium hydrogenphosphate 35.0 35.0 35.0 35.0 35.0
Sodium lauryl 1.0 1.0 1.0 1.0 1.0
sulfate
Saccharin 0.1 0.1 0.1 0.1 0.1
sodium
Ethylparaben 0.1 0.1 0.1 0.1 0.1
Total 100.0 100.0 100.0 100.0 100.0
State stability
after storage O O O X O
at
GOC for 1
month
State stability
after storage O O O X O
at
50C for 2
months
Storage at GOC
Fluorine 95 94 45 94 41
ion for 1 week
residue (%) Storage at GOC
92 90 35 91 39
for 2 weeks
3. Quantitative test of E-aminocaproic acid
Tooth pastes shown in Table 3 were prepared and stored under severe
conditions shown below. After the storage under severe conditions, the
quantity
of E-aminocaproic acid in each tooth paste was determined by the liquid
17
CA 02504797 2005-05-03
OP05014
chromatography under the following conditions.
[Severe storage conditions]
1. Storage in a constant temperature bath at GO°C for one month
2. Storage in a constant temperature bath at 50°C for two months
[Test conditions]
Detector: Fluorescent detector (excitation wave length: 390 nm, fluoresce wave
length: 480 nm)
Column: Octadecylsilylated silica gel for high-performance liquid
chromatography (5 to 10 ~.c m) was fed into a stainless steel tube having an
inner
diameter of 4.G mm and a length of 250 mm.
Column temperature: 40°C
Mobile phase: Phosphoric acid solution / acetonitrile mixture
Flow rate: 1.0 ml/min
The residual rate of ~-aminocaproic acid was determined according to the
following formula (2):
[Formula (2)]
Residual rate (%) _ [(Amount of ~-aminocaproic acid after the storage
under severe conditions) / (Amount of E-aminocaproic acid immediately
after the preparation of tooth paste)
When f -aminocaproic acid residual rate in the tooth paste stored under
the severe conditions was 90 % or higher, F -aminocaproic acid was judged to
be
stable.
The storability tests of the tooth pastes shown in Table 3 were carried out
in the same manner as that in above item 1.
18
CA 02504797 2005-05-03
OP05014
Table 3
Example Comp. Ref.
Ex.
Component (%)
5 G 7 8 Ex.2
Hydroxypropylcellulose
3.0 3.0 - - 3.0
(Viscosity 150-400
mPa/S)
1,3-Butylene 5G.7 44.7 15.7 44.7 14.7
glycol
Silicic acid - 12.0 12.0 12.0 12.0
anhydride
Carrageenan - - 2.0 3.0 -
Water - - 30.0 - 30.0
f -Aminocaproic 0.1 0.1 0.1 0.1 0.1
acid
Aluminum hydroxide 35.0 35.0 35.0 35.0 35.0
Polyoxyethylene
hydrogenated
5.0 5.0 5.0 5.0 5.0
castor oil
Saccharin sodium 0.1 0.1 0.1 0.1 0.1
Ethylp araben 0.1 0.1 0.1 0.1 0.1
Total 100.0 100.0 100.0 100.0 100.0
State stability
after storage
at GOC
O O O X O
for 1 month
State stability
after storage
at 50C
O O O X O
for 2 months I
i
Storage at
GOC
Residual rate 100 100 82 99 81
of
for 1 month
E-aminocaproic
Storage at t
50C
acid (%) 100 100 82 99 82
for 2 months
4. Quantitative test of sodium ascorbate
Tooth pastes shown in Table 4 were prepared and stored under severe
19
CA 02504797 2005-05-03
OP05014
conditions shown below. After the storage under severe conditions, the
quantity
of sodium ascorbate in each tooth paste was determined by the liquid
chromatography under the following conditions.
[Severe storage conditions]
1. Storage in a constant temperature bath at GO°C for one month
2. Storage in a constant temperature bath at 50°C for two months
[Test conditions]
Detector: Ultraviolet absorption spectrophotometer (determination wave length:
245 nm)
Column: 5 a m of octadecylsilylated silica gel for high-performance liquid
chromatography was fed into a stainless steel tube having an inner diameter of
4.G mm and a length of 250 mm.
Column temperature: 40°C
Mobile phase: Metaphosphoric acid solution
Flow rate: 1.0 ml/min
The residual rate of sodium ascorbate was determined according to the
following formula (3):
[Formula (3)]
Residual rate (%) _ [(Amount of sodium ascorbate after the storage under
severe conditions) / (Amount of sodium ascorbate immediately after the
preparation of tooth paste)] X 100
When sodium ascorbate residual rate of the tooth paste stored under the
severe conditions was 90 % or higher, sodium ascorbate was judged to be
stable.
The storability tests of the tooth pastes shown in Table 4 were carried out
in the same manner as that in above item 1.
CA 02504797 2005-05-03
OP05014
Table 4
Example Comp. Ref.
Ex.
Component
(%)
7 8 9 10 Ex.
3
Hydroxypropylcellulose
3.0 3.0 - - 3.0
(Viscosity
150-400 mPa/S)
1,3-Butylene 58.9 46.9 17.9 4G.9 1G.9
glycol
Silicic acid - 12.0 12.0 12.0 12.0
anhydride
Carrageenan - - 2.0 3.0 -
Water - - 30.0 - 30.0
Sodium ascorbate 1.0 1.0 1.0 1.0 1.0
Aluminum hydroxide 35.0 35.0 35.0 35.0 35.0
Sodium lauryl 1.0 1.0 1.0 1.0 1.0
sulfate
Saccharin 1.0 1.0 1.0 1.0 1.0
sodium
Ethylparaben 0.1 0.1 0.1 0.1 0.1
Total 100.0 100.0 100.0 100.0 100.0
State stability
after storage
at
O O O X O
GOC for 1
month
State stability
after storage
at
O O O X O
50C for 2
months
Storage at GOC
Residual rate 93 94 35 93 38
for 1 month
of sodium
Storage at 50C
ascorbate 97 9G 38 9G 37
(%)
for 2 months
The following facts will be understood from the above-described results of
the experiments: It is understood from the results shown in Table 1 that by
using the base for the oral composition of the present invention, the obtained
21
CA 02504797 2005-05-03
OP05014
tooth paste has the separation-free state and excellent storability. It is
understood from the results shown in Tables 2 to 4 that the tooth pastes each
comprising the oral composition of the present invention has an excellent
stability
and also a high storability of the fluoride, E-aminocaproic acid, ascorbic
acid and
salts thereof.
The results of the experiments of tooth pastes in Examples 9 to 22
prepared by an ordinary method were similar to those described above.
Example 9
Preparation of a dental paste
Hydroxypropylcellulose (viscosity 150-400 3.0 % by weight
mPa/S)
Polyethylene glycol 49.65
Crystalline cellulose 10.0
Aluminum hydroxide 35.0
Sodium lauryl sulfate 1.0
Saccharin sodium 0.1
Paraben 0.1
Flavor 1.0
Tocopherol acetate 0.1
Cetyl pyridinium chloride 0.05
Total 100.0 % by weight
Example 10
Prep aration of a dental p aste
Hydroxypropylcellulose (viscosity 1000-4000 mPa/S) 1.0 % by weight
Diglycerol 23.0
Propylene glycol 23.17
Sihcic acid anhydride 5.0
22
CA 02504797 2005-05-03
OP05014-
Crystalline cellulose 10.0
Sodium fluoride 0.2
Calcium carbonate 35.0
Sodium lauryl sulfate 1.0
Sodium lauroyl sarcosine 0.3
Stevia extract 0.1
Sodium benzoate 0.1
Flavor 1.0
Dipotassium glycyrrhizinate 0.1
Isopropylmethylphenol 0.03
Total 100.0 % by weight
Example 11
Preparation of a dental paste
Hydroxypropylcellulose (viscosity 2-3 mPa/S)10.0 % by weight
Concentrated glycerol 19.0
Polyethylene glycol 10.0
1,3-Butylene glycol 10.8
Sihcic acid anhydride 10.0
E-Aminocaproic acid 0.1
Tin fluoride 0.1
Calcium hydrogenphosphate for dentifrices 25.0
Sucrose fatty acid esters 0.5
Xylitol 10.0
Carrageenan 0.3
Paraben 0.1
Flavor 1.0
23
CA 02504797 2005-05-03
OP05014
Purified water 3.0
S-glycyrrhetinic acid 0.05
Chlorhexidine hydrochloride 0.05
Total 100.0 % by weight
Example 12
Preparation of a dental paste
Hydroxypropylcellulose (viscosity 6-10 mPa/S)10.0 % by weight
Concentrated glycerol 34.45
Polyethylene glycol 10.0
Silicic acid anhydride 10.0
a -TCP 30.0
Sodium fluoride 0.2
Sodium lauryl sulfate 1.0
Polyoxyethylene hydrogenated castor oil 3.0
Saccharin sodium 0.1
Paraben 0.1
Flavor 1.0
Tocopherol acetate 0.1
Glycyrrhizin 0.05
Total 100.0 % by weight
Example 13
Preparation of a dental paste
Hydroxypropylcellulose (viscosity 150-400 mPa/S) 3.0 % by weight
Concentrated glycerol 54.95
24
CA 02504797 2005-05-03
OP05014
Silicic acid anhycli~ide 20.0
Hydrous sihcic acid 10.0
Crystalline cellulose 8.0
Chlorinated lysozyme 0.5
Sodium lauryl sulfate 1.0
Sodium lauroyl sarcosine 0.3
Stevia extract 0.1
Paraben 0.1
Flavor 1.0
Zeolite 1.0
Cetylpyridinium chloride 0.05
Total 100.0 % by weight
Example 14
Preparation of a dental paste
Hydroxypropylcellulose (viscosity G-10 mPa/S) 5.0 % by weight
Concentrated glycerol 23.7
Polyethylene glycol 20.0
Silicic acid anhydride 10.0
Hinokitiol 0.05
f -Aminocaproic acid 0.1
Calcium hydrogenphosphate for dentifirices 15.0
Polyoxyethylene hydrogenated castor oil 5.0
Trehalose 5.0
Sorbitol 5.0
Alkyldiaminoethylglycine hydrochloride solution0.05
Flavor 1.0
CA 02504797 2005-05-03
OP05014
Sodium chloride 10.0
Tocopherol acetate 0.1
Total 100.0 % by weight
Example 15
Preparation of a dental paste
Hydroxypropylcellulose (viscosity 150-400 mPa/S)3.0 % by weight
Polyethylene glycol 20.0
1,3-Butylene glycol 30.25
Silicic acid anhydride 10.0
Hydrous silicic acid 20.0
Crystalline cellulose 10.0
a -TCP 3.0
Sodium fluoride 0.2
Sodium lauryl sulfate 1.0
Sodium lauroyl sarcosine 0.3
Stevia extract 0.1
Paraben 0.1
Flavor 1.0
Zeolite 1.0
Cetylpyridinium chloride 0.05
Total 100.0 % by weight
Example 1G
Pr ep aration of a dental p aste
Hydroxypropylcellulose (viscosity 150-400 mPa/S) 3.0 % by weight
2G
CA 02504797 2005-05-03
OP05014
Polyethylene glycol 20.0
1,3-Butylene glycol 63.25
Silicic acid anhydxzde 10.0
Sodium lauryl sulfate 1.0
Saccharin sodium 0.5
Paraben 0.1
Flavor 1.0
Sodium ascorbate 1.0
Tocopherol acetate 0.1
Cetylpyridinium chloride 0.05
Total 100.0 % by weight
Example 17
Preparation of a dental paste
Hydroxypropylcellulose (viscosity 1000-4000 1.0 % by weight
mPa/S)
Polyethylene glycol 20.0
1,3-Butylene glycol 46.57
Silicic acid anhydride 5.0
Calcium hydrogenphosphate for dentifrices 20.0
Glycerol fatty acid ester 3.0
Stevia extract 0.1
Sodium benzoate 1.0
Flavor 1.0
Sodium ascorbate 2.0
Sodium fluoride 0.2
Dipotassium glycyrrhizinate 0.1
Isopropylmethylphenol 0.03
27
CA 02504797 2005-05-03
OP05014
Total 100.0 % by weight
Example 18
Preparation of a dental paste
Hydroxypropylcellulose (viscosity 150-400 mPa/S)1.5 % by weight
Hydroxypropylcellulose (viscosity 1000-4000 0.5 % by weight
mPa/S)
Polyethylene glycol 10.0
1,3-Butylene glycol 37.2
Silicic acid anhydride 10.0
Calcium hydrogenphosphate for dentifrices 25.0
Sucrose fatty acid ester 0.5
Polyoxyethylene hycliogenated castor oil 3.0
Xylitol
10.0
Paraben 0.1
Flavor 1.0
Purified water 1.0
Ascorbic acid 0.1
(3 -glycyrrhetinic acid 0.05
Chlorhexidine hydrochloride 0.05
Total 100.0 % by weight
Example 19
2 5 Pr ep ar ation of a dental p rite
Hydroxypropylcellulose (viscosity G-10 mPa/S) 10.0 % by weight
Polyethylene glycol 15.0
1,3-Butylene glycol 52.55
28
CA 02504797 2005-05-03
OP05014
Silicic acid anhydride 10.0
Sodium monofluorophosphate 0.7
Sodium lauryl sulfate 1.0
Polyoxyethylene hydrogenated castor oil 3.0
Saccharin sodium 1.0
Paraben 0.1
Flavor 1.0
Ascorbic acid 0.5
Zeolite 5.0
Tocopherol acetate 0.1
Glycyrrhizin 0.05
Total 100.0 % by weight
Example 20
Preparation of a dental paste
Hydroxypropylcellulose (viscosity 150-400 mPa/S)3.0 % by weight
Concentrated glycerol 30.0
Propylene glycol 2G.G5
Silicic acid anhydride 10.0
Calcium hydrogenphosphate for dentifrices 20.0
Glycerol fatty acid ester 1.0
Polyoxyethylene hydrogenated castor oil 2.0
Stevia extract 0.1
Paraben 0.1
Flavor 1.0
Sodium ascorbate 5.0
Tocopherol acetate 0.1
29
CA 02504797 2005-05-03
OP05014
Zeolite 1.0
Cetyl pyridinium chloride 0.05
Total 100.0 % by weight
Example 21
Preparation of a dental paste
Hydroxypropylcellulose (viscosity 150-400 mPa/S)2.0 % by weight
1,3-Butylene glycol 49.6
Polyethylene glycol 10.0
Silicic acid anhydride 10.0
Calcium carbonate 20.0
Polyoxyethylene hydrogenated castor oil 3.0
Saccharin sodium 1.0
Xylitol 1.0
Sodium lauryl sulfate 1.0
Paraben 0.1
Flavor 1.0
Sodium ascorbate 1.0
Cetyl pyridinium chloride 0.05
(3 -Glycyrrhetinic acid 0.05
Sodium fluoride 0.2
Total 100.0 % by weight
Example 22
Preparation of a dental paste
Hydroxypropylcellulose (viscosity 150-400 mPa/S) 3.0 % by weight
CA 02504797 2005-05-03
OP05014
1,3-Butylene glycol 45.1
Polyethylene glycol 10.0
Silicic acid anhydride G.0
Zeolite 5.0
Calcium hydrogenphosphate for dentifrices 17.0
Anhydrous ethanol 5.5
Titanium oxide 3.0
Sodium lauryl sulfate 1.8
Saccharin sodium 1.0
Dibutylhydroxytoluene 0.5
Magnesium phosphate 0.3
1-Menthol 0.3
Peppermint oil 0.2
Par aben 0.1
Colorant 0.1
Sodium ascorbate 1.0
Tocopherol acetate 0.1
Total 100.0 % by weight
Industrial Applicability
By using the base for the oral composition of the present invention, a
highly stable, non-aqueous oral composition having a high shape retention can
be
obtained. It is also possible to obtain a non-aqueous oral composition having
excellent shape-retainilig property and stability to aging, in which the
active
ingredients are stably maintained and the solid component is not separated
from
the liquid component, by combinilig the base for the oral composition of the
present invention with an active ingredient usually unstable in the presence
of
31
CA 02504797 2005-05-03
OP05014
water, which is selected from the group consisting of n: -TCP, fluorides,
enzymes,
hinokitiol, ~ -aminocaproic acid, ascorbic acid and ascorbic acid salts.
32
